Translational lung cancer research

Keyphrases

Publications

volume 13, number 7, 2024

Haohua Jiang, Yujing Li, Yanan Wang, Benkun Zou, Ya Chen, Yanwei Zhang, Hatim Husain, Fabien Forest, Fangfei Qian, Lele Zhang, Chao Zhou, Hongyu Liu, Danni Wang, Wei Zhang, Jun Lu, Baohui Han
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study. Translational lung cancer research 13 (7) (2024)
Yi Li, Bingxin Gong, Jie Lou, Yusheng Guo, Bo Liang, Weiwei Liu, Ziang You, Chao Chen, Bin Chai, Shanshan Jiang, Hongyong Zhang, Feng Pan, Lian Yang, Guofeng Zhou
Association between thymus density loss and efficacy in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Translational lung cancer research 13 (7) (2024)
Yang Du, Xiao-Yan Liu, Xiao-Yan Si, Xiao-Tong Zhang, Jing-Ya Zhou, Yi Wang, Min-Jiang Chen, Li Zhang
Comparative efficacy and safety of anlotinib and topotecan as second-line treatment in small cell lung cancer: a retrospective cohort study. Translational lung cancer research 13 (7) (2024)
Tengyong Wang, Zihuai Wang, Hui Jie, Chengwu Liu, Shiyou Wei, Hu Liao, Jiandong Mei, Qiang Pu, Lunxu Liu
Lymph node dissection of station 8 improves the survival of T ≤3 cm N0M0 lung adenocarcinoma patients. Translational lung cancer research 13 (7) (2024)
Mingyang Zhu, Yuanyuan Xu, Jiazheng Huang, Yaxian Yao, Davide Tosi, Terumoto Koike, Nestor R Villamizar, Ziang Wang, Feng Mao, Qingquan Luo, Qiang Tan
Sublobar resection for lung adenocarcinoma less than 2 cm containing solid or micropapillary components radiologically presented as consolidation-to-tumor ratio (CTR) ≤0.25 [ground-glass opacity (GGO)]. Translational lung cancer research 13 (7) (2024)
Taketo Kato, Hironori Oyamatsu, Yuki Hanamatsu, Heng Huang, Shoji Okado, Yoshito Imamura, Yuji Nomata, Hiroki Watanabe, Yuka Kadomatsu, Harushi Ueno, Shota Nakamura, Tetsuya Mizuno, Tetsunari Hase, Tamotsu Takeuchi, Toyofumi Fengshi Chen-Yoshikawa
Transcriptomic profiling of a late recurrent nuclear protein in testis carcinoma of the lung 14 years after the initial operation: a case report. Translational lung cancer research 13 (7) (2024)
Stanislav Fridland, Hye Sung Kim, Young Kwang Chae
Differential impact of intratumor heterogeneity (ITH) on survival outcomes in early-stage lung squamous and adenocarcinoma based on tumor mutational burden (TMB). Translational lung cancer research 13 (7) (2024)
Yuchen Huang, Wananqi Ma, Dongsheng Wu, Mengyuan Lyu, Quan Zheng, Tengyong Wang, Jian Zhou, Chengwu Liu
Prognostic relevance of immune-related adverse events in lung cancer patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. Translational lung cancer research 13 (7) (2024)
Mariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, Anna Caliò, Stefano Marletta, Tommaso Bondavalli, Diego Giongo, Daniela Reghellin, Ilaria Posenato, Maria Santacatterina, Andrea Menin, Patrick Karl Welte, Francesca Baciorri, Diana Sacchi, Cosimo Catino, Lorenzo Nicolè, Gabriele Foltran, Alessandra D'Urso, Nicla Orzes, Giulia Andreotti, Patrizia Bartolotta, Dario Gregori, Giulia Pasello, Federico Rea, Fiorella Calabrese
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers. Translational lung cancer research 13 (7) (2024)
Qian Cai, Kui Hu, Shuang Dong, Xiaoyu Li, Sheng Hu, Wenyou Deng, Wulin Ou
Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib. Translational lung cancer research 13 (7) (2024)
Mau-Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan, Muhammad Adil Zainal Abidin, Chong Kin Liam, Jiunn Liang Tan, Yong Kek Pang, Arvindran Alaga, Lye Mun Tho, Soon Hin How
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer. Translational lung cancer research 13 (7) (2024)
Yunchang Meng, Yimin Wang, Leilei Liu, Ranpu Wu, Qingfeng Zhang, Zhangxuan Chen, Yang Yao, Xinjing Li, Yanzhuo Gong, Huijuan Li, Zhaofeng Wang, Hongbing Liu
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors. Translational lung cancer research 13 (7) (2024)
Rafael Parra-Medina, Juan Pablo Castañeda-González, Luisa Montoya, María Paula Gómez-Gómez, Daniel Clavijo Cabezas, Merideidy Plazas Vargas
PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis. Translational lung cancer research 13 (7) (2024)
Chaoqiang Deng, Chenyu Jiang, Xiangyi Ma, Fangqiu Fu, Shengping Wang, Yuan Li, Yang Zhang, Haiquan Chen
Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor? Translational lung cancer research 13 (7) (2024)
Jeong Uk Lim, Hye Seon Kang, Mi Hyoung Moon, Chang Dong Yeo, Young Jo Sa, Tae-Jung Kim, Deog Gon Cho, Kyung Soo Kim
PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer. Translational lung cancer research 13 (7) (2024)
Li Lu, Zhengqi Cao, Anni Wang, Lixuan Chen, Jing Sun, Ziming Li
Pathological complete response to neoadjuvant lorlatinib in a patient with stage IIIA ALK -positive non-small cell lung cancer: a case report. Translational lung cancer research 13 (7) (2024)
Gabriela Krakorova, Petr Domecky, Jiri Blazek, Milos Pesek, Ondrej Venclicek, Libor Havel, Michal Hrnciarik, Jana Krejci, Andrea Mullerova, Miloslav Marel, Jaroslav Duba, Martin Svaton
Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data. Translational lung cancer research 13 (7) (2024)
Iris E W G Laven, Vincent P S Oosterhoff, Aimée J P M Franssen, Lori M van Roozendaal, Karel W E Hulsewé, Yvonne L J Vissers, Erik Robert de Loos
Evaluating three-dimensional lung reconstructions for thoracoscopic lung resections using open-source software: a pilot study. Translational lung cancer research 13 (7) (2024)

volume 13, number 8, 2024

Xuchang Li, Yangchen Xia, Chengyan Wang, Shanshan Huang, Qian Chu
Efficacy of ALK inhibitors in Asian patients with ALK inhibitor-naïve advanced ALK -positive non-small cell lung cancer: a systematic review and network meta-analysis. Translational lung cancer research 13 (8) (2024)
Mei-Na Piao, Jing Xie, Min-Min Jin, Xiao-Ting Ma, Zheng Dou, Jian-Ping Wang, Jin-Li Li
Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study. Translational lung cancer research 13 (8) (2024)
Esther Garcia-Lorenzo, Victor Moreno
Are PD-1T TILs merely an expensive and unuseful whim as biomarker? Translational lung cancer research 13 (8) (2024)
Haoyou Wang, Wei Wang, Peng Zu, Gregor J Kocher, Mara B Antonoff, Alberto Lopez-Pastorini, Chenlei Zhang, Wei Chen, Hongxu Liu
Single-center clinical experience of extended sleeve lobectomy (ESL) versus standard sleeve lobectomy (SL). Translational lung cancer research 13 (8) (2024)
Hirokazu Taniguchi, Kazuto Ashizawa, Hiroshi Mukae
Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer? Translational lung cancer research 13 (8) (2024)
Dan Pu, Hong-E Zhang, Lu Li
Immune-related osteoblastic bone alterations mimicking bone metastasis in a small-cell lung cancer patient treated with durvalumab: a case report. Translational lung cancer research 13 (8) (2024)
Nagla Abdel Karim, Mohamed Zaza, Janakiraman Subramanian
Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line? Translational lung cancer research 13 (8) (2024)
Nobutaka Kataoka, Yuki Katayama, Tadaaki Yamada, Kenji Morimoto, Takayuki Takeda, Asuka Okada, Shinsuke Shiotsu, Yusuke Chihara, Osamu Hiranuma, Takahiro Yamada, Takahiro Ota, Taishi Harada, Isao Hasegawa, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study. Translational lung cancer research 13 (8) (2024)
Yunlong Li, Chenmei Li, Jiamin Li, Dong Han, Gang Xu, Daolong Zhu, Huiming Cai, Yiqing Wang, Dong Wang
Enhanced tumor targeting and penetration of fluorophores via iRGD peptide conjugation: a strategy for the precision targeting of lung cancer. Translational lung cancer research 13 (8) (2024)
Agata Durawa, Katarzyna Dziadziuszko, Małgorzata Jelitto, Michał Gąsiorowski, Mariusz Kaszubowski, Edyta Szurowska, Witold Rzyman
Emphysema and lung cancer risk. Translational lung cancer research 13 (8) (2024)
Tengyong Wang, Zihuai Wang, Jian Zhou, Hui Jie, Hu Liao, Jiandong Mei, Qiang Pu, Lunxu Liu
A nomogram predicting the risk of extrathoracic metastasis at initial diagnosis of T ≤3cm N 0 lung cancer. Translational lung cancer research 13 (8) (2024)
Abdi T Gudina, Charles Kamen, Lindsey J Mattick, Francisco Cartujano-Barrera, Michelle C Janelsins, Deborah Ossip, M Patricia Rivera, Kevin Fiscella, Ana-Paula Cupertino
Knowledge and beliefs about lung cancer screening among Black individuals at high risk: a qualitative approach. Translational lung cancer research 13 (8) (2024)
Yi Feng, Caichen Li, Bo Cheng, Ying Chen, Peiling Chen, Zixun Wang, Xiangyuan Zheng, Juan He, Feng Zhu, Wei Wang, Wenhua Liang
Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome. Translational lung cancer research 13 (8) (2024)
Liang Guo, Juanjuan Li, Jing Wang, Xinru Chen, Chenlei Cai, Fei Zhou, Anwen Xiong
Prognostic role of dynamic changes in inflammatory indicators in patients with non-small cell lung cancer treated with immune checkpoint inhibitors-a retrospective cohort study. Translational lung cancer research 13 (8) (2024)
Bin Liu, Ziyu Wang, Meng Gu, Jinghui Wang, Jinjing Tan
Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review. Translational lung cancer research 13 (8) (2024)
Lin Xu, Wenjie Xia, Rong Yin, Ninglei Qiu
Successful carinal reconstruction with right main bronchial flap rotational embedded augmentation: a case report. Translational lung cancer research 13 (8) (2024)
Xiaoyu Song, Li Li, Qingxi Yu, Ning Liu, Shouhui Zhu, Shuanghu Yuan
Radiogenomics models for predicting prognosis in locally advanced non-small cell lung cancer patients undergoing definitive chemoradiotherapy. Translational lung cancer research 13 (8) (2024)
Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo Ye
Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 13 (8) (2024)
Feichao Bao, Jiaming Wang, Chen Shen, Fenghao Yu, Marko Jakopović, Xiuxiu Hao, Yang Chen, Yiyang Wang, Zhitao Gu, Wentao Fang
Effective induction immunotherapy minimizes surgical invasiveness for locally advanced lung cancer. Translational lung cancer research 13 (8) (2024)
Youyu Wang, Dongfang Li, Qiang Li, Alina Basnet, Jimmy T Efird, Nobuhiko Seki
Neutrophil estimation and prognosis analysis based on existing lung squamous cell carcinoma datasets: the development and validation of a prognosis prediction model. Translational lung cancer research 13 (8) (2024)
Koen C H A Verkoulen, Iris E W G Laven, Jean H T Daemen, Juliette H R J Degens, Lizza E L Hendriks, Karel W E Hulsewé, Yvonne L J Vissers, Erik Robert de Loos
The (un)lucky seven-how can we mitigate risk factors for postoperative pneumonia after lung resections? Translational lung cancer research 13 (8) (2024)
Clémence Pierre, Yannick Le Guen, Caroline Giordanengo, Thomas Goter, Hervé Léna, Clémence Niel, Gonzague De Chabot, Marie Tiercin, Gwenaelle Le Garff, François Zimmermann, Quentin Le Cornu, Charles Ricordel
Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study. Translational lung cancer research 13 (8) (2024)
So-Yun Kim, Dongil Park, Pureum Sun, Nayoung Kim, Dahye Lee, Duk Ki Kim, Song-I Lee, Jeong Eun Lee, Chaeuk Chung, Da Hyun Kang
Prognostic and predictive significance of soluble programmed death ligand 1 in bronchoalveolar lavage fluid in stage IV non-small cell lung cancer. Translational lung cancer research 13 (8) (2024)
Jinyu Long, Ying Chen, Xingguang Luo, Ruiying Rao, Chenxi Wang, Yuxin Guo, Jinhe Xu, Ping Lin, Yingfang Song, Lijuan Qu, Qinghong Liu, Jun Lu, Chengzhi Zhou, Zhengbo Song, Xiandong Lin, Hiroyuki Adachi, Jacek Jassem, Masatsugu Hamaji, Zongyang Yu
Clinical features and prognostic biomarkers in patients with SMARCA4 -mutated non-small cell lung cancer. Translational lung cancer research 13 (8) (2024)
Bobby Se, Athar Eysa, Nagla Karim
Clinical insights: five-year follow-up of KEYNOTE-189 trial outcomes and more. Translational lung cancer research 13 (8) (2024)
Jian Zhou, Quan Zheng, Yuchen Huang, Mengyuan Lyu, Tengyong Wang, Dongsheng Wu, Hu Liao
Effect of family history of cancer on postoperative survival in patients with non-small cell lung cancer. Translational lung cancer research 13 (8) (2024)
Xin Wen, Meng-Wen Liu, Bin Qiu, Yan-Mei Wang, Jiu-Ming Jiang, Xue Zhang, Xu Jiang, Lin Li, Meng Li, Li Zhang
CT-based radiomic consensus clustering association with tumor biological behavior in clinical stage IA adenocarcinoma: a retrospective study. Translational lung cancer research 13 (8) (2024)
Julie Dardare, Andréa Witz, Alexandre Harlé
REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer? Translational lung cancer research 13 (8) (2024)
Se-Il Go, Jung Wook Yang, Eun Jeong Jeong, Woo Je Lee, Sungwoo Park, Dae Hyun Song, Gyeong-Won Lee
Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicator. Translational lung cancer research 13 (8) (2024)
David Xiao, Michael N Kammer, Heidi Chen, Palina Woodhouse, Kim L Sandler, Anna E Baron, David O Wilson, Ehab Billatos, Jiantao Pu, Fabien Maldonado, Stephen A Deppen, Eric L Grogan
Assessing the transportability of radiomic models for lung cancer diagnosis: commercial vs. open-source feature extractors. Translational lung cancer research 13 (8) (2024)
Mora Guardamagna, May-Lucie Meyer, Miguel-Angel Berciano-Guerrero, Andres Mesas-Ruiz, Manuel Cobo-Dols, Elisabeth Perez-Ruiz, Alexandra Cantero Gonzalez, Rocío Lavado-Valenzuela, Isabel Barragán, Javier Oliver, Alicia Garrido-Aranda, Martina Alvarez, Antonio Rueda-Dominguez, María Isabel Queipo-Ortuño, Emilio Alba Conejo, Jose Carlos Benitez
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative review. Translational lung cancer research 13 (8) (2024)
Haoda Huang, Zeping Yan, Bingliang Li, Weixiang Lu, Ping He, Lei Fan, Xiaowei Wu, Hengrui Liang, Jianxing He
LungPath : artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinoma. Translational lung cancer research 13 (8) (2024)